Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells. - Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM (International journal of environmental research and public health, 2022)